FindTrial
Sign In

Population pharmacokinetics and individualized administration of levetiracetam in epileptic patients with diabetes and kidney disease

Population pharmacokinetics and individualized administration of levetiracetam in epileptic patients with diabetes and kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090189
Enrollment
Unknown
Registered
2024-09-25
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy with diabetes nephropathy

Interventions

case series:none

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Epileptic seizures, treated with levetiracetam, Diabetes nephropathy, Age = 18 years old

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Blood drug concentration;—

Countries

China

Contacts

Public ContactChao Sun

The Second Hospital of Shandong University

260863147@qq.com+86 187 5310 7057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026